46/100BTarget stock forecast 2027–2031What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Target is 166.95, 4.4% above the current price of 159.84. Their targets range from 140.00 to 200.00.
Of the 29 firms that rated Target in the past 12 months, 12 rate it buy or strong buy, 14 hold and 3 sell or strong sell (each firm at its latest rating): a Hold consensus.
Analysts' 1-year price targets range from 140.00 to 200.00, with an average of 166.95.
| Buy | 12 | |
| Hold | 14 | |
| Sell | 3 |
12-month price target
| Highest target | 200.00 |
| Average target | 166.95 |
| Lowest target | 140.00 |
| Current price | 159.84 |
Target price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Target price target and rating?
How analysts rate Target, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
12 of 29 firms rate it buy now, against 9 of 27 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Target analyst upgrades, downgrades and price targets
The latest rating change came on 30 September 2026, when HSBC upgraded Target from Hold to Buy. Its price target is 190.00. The most recent new target came from Evercore ISI on 13 October 2026: 165.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 13 Oct 2026 | Evercore ISI | Reiterated · In Line | 170.00 → 165.00 | -2.9% | 152.76 |
| 30 Sept 2026 | HSBC | Upgraded · Hold → Buy | 190.00 | — | 156.45 |
| 20 Aug 2026 | Deutsche Bank | — | 140.00 → 150.00 | +7.1% | 159.14 |
| 20 Aug 2026 | RBC Capital | Reiterated · Outperform | 166.00 → 178.00 | +7.2% | 159.68 |
| 20 Aug 2026 | Truist Financial | Reiterated · Hold | 147.00 → 167.00 | +13.6% | 158.81 |
| 20 Aug 2026 | Evercore ISI | Reiterated · In Line | 150.00 → 170.00 | +13.3% | 159.03 |
| 20 Aug 2026 | Roth Capital | — | 114.00 → 142.00 | +24.6% | 159.03 |
| 20 Aug 2026 | Robert W. Baird | — | 135.00 → 170.00 | +25.9% | 159.03 |
| 20 Aug 2026 | Gordon Haskett Capital Corporation | — | 200.00 | — | 159.03 |
| 20 Aug 2026 | Piper Sandler | Reiterated · Neutral | 146.00 → 153.00 | +4.8% | 159.03 |
| 20 Aug 2026 | Bernstein | — | 124.00 → 154.00 | +24.2% | 159.03 |
| 20 Aug 2026 | Guggenheim John Heinbockel | Reiterated · Buy | 150.00 → 175.00 | +16.7% | 159.03 |
| 20 Aug 2026 | Mizuho Securities | — | 120.00 → 150.00 | +25.0% | 159.03 |
| 20 Aug 2026 | Goldman Sachs Kate McShane | Reiterated · Neutral | 127.00 → 161.00 | +26.8% | 159.03 |
| 20 Aug 2026 | Wells Fargo | Reiterated · Overweight | 165.00 → 185.00 | +12.1% | 159.03 |
| 20 Aug 2026 | Telsey Advisory Joseph Feldman | Reiterated · Outperform | 170.00 → 182.00 | +7.1% | 159.03 |
| 20 Aug 2026 | BMO Capital Kelly Bania | Reiterated · Market Perform | 150.00 → 160.00 | +6.7% | 159.03 |
| 19 Aug 2026 | D.A. Davidson | — | 170.00 → 185.00 | +8.8% | 159.03 |
| 19 Aug 2026 | Barclays | — | 115.00 → 140.00 | +21.7% | 161.24 |
| 17 Aug 2026 | D.A. Davidson | — | 155.00 → 170.00 | +9.7% | 154.43 |
| 14 Aug 2026 | Truist Financial | Reiterated · Hold | 130.00 → 147.00 | +13.1% | 154.69 |
| 14 Aug 2026 | Deutsche Bank | — | 123.00 → 140.00 | +13.8% | 155.47 |
| 14 Aug 2026 | Piper Sandler | Reiterated · Neutral | 127.00 → 146.00 | +15.0% | 155.93 |
| 14 Aug 2026 | Jefferies | Reiterated · Buy | 161.00 → 177.00 | +9.9% | 155.51 |
| 14 Aug 2026 | Telsey Advisory Joseph Feldman | Reiterated · Outperform | 150.00 → 170.00 | +13.3% | 155.51 |
| 12 Aug 2026 | RBC Capital Steven Shemesh | Reiterated · Outperform | 153.00 → 166.00 | +8.5% | 152.33 |
| 11 Aug 2026 | BMO Capital | Reiterated · Market Perform | 90.00 → 150.00 | +66.7% | 152.09 |
| 11 Aug 2026 | Oppenheimer Rupesh Parikh | Reiterated · Outperform | 170.00 | — | 152.09 |
| 4 Aug 2026 | Evercore ISI Greg Melich | Reiterated · In Line | 130.00 → 150.00 | +15.4% | 147.87 |
| 3 Aug 2026 | Wolfe Research | — | 162.00 → 169.00 | +4.3% | 144.47 |
| 30 Jul 2026 | Wells Fargo Edward Kelly | Reiterated · Overweight | 140.00 → 165.00 | +17.9% | 145.97 |
| 20 Jul 2026 | Guggenheim | Reiterated · Buy | 145.00 → 150.00 | +3.4% | 139.62 |
| 26 Jun 2026 | Jefferies | Reiterated · Buy | 115.00 → 161.00 | +40.0% | 140.79 |
| 23 Jun 2026 | Wolfe Research Spencer Hanus | Upgraded · Peer Perform → Outperform | 81.00 → 162.00 | +100.0% | 129.77 |
| 12 Jun 2026 | Guggenheim | Reiterated · Buy | 140.00 → 145.00 | +3.6% | 132.64 |
| 22 May 2026 | Argus Research | — | 150.00 | — | 126.17 |
| 22 May 2026 | Roth Capital | — | 88.00 → 114.00 | +29.5% | 126.61 |
| 22 May 2026 | D.A. Davidson Michael Baker | — | 140.00 → 155.00 | +10.7% | 126.19 |
| 21 May 2026 | Telsey Advisory | Reiterated · Outperform | 148.00 → 150.00 | +1.4% | 122.17 |
| 21 May 2026 | Bernstein Zhihan Ma | — | 116.00 → 124.00 | +6.9% | 121.87 |
| 21 May 2026 | RBC Capital | Reiterated · Outperform | 132.00 → 153.00 | +15.9% | 119.29 |
| 21 May 2026 | Piper Sandler | Reiterated · Neutral | 121.00 → 127.00 | +5.0% | 122.33 |
| 21 May 2026 | Goldman Sachs Kate McShane | Reiterated · Neutral | 127.00 | — | 122.33 |
| 21 May 2026 | Robert W. Baird | — | 92.00 → 135.00 | +46.7% | 122.33 |
| 20 May 2026 | Truist Financial Scot Ciccarelli | — | 123.00 → 130.00 | +5.7% | 122.33 |
| 20 May 2026 | Guggenheim John Heinbockel | — | 125.00 → 140.00 | +12.0% | 127.27 |
| 20 May 2026 | Freedom Broker | Downgraded · Buy → Hold | — | — | — |
| 18 May 2026 | Evercore ISI Greg Melich | — | 125.00 → 130.00 | +4.0% | 122.91 |
| 15 May 2026 | Telsey Advisory | — | 110.00 → 148.00 | +34.5% | 121.53 |
| 15 May 2026 | Deutsche Bank Krisztina Katai | — | 108.00 → 123.00 | +13.9% | 122.37 |
Target EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Target's EPS to grow 5.9% a year until 2028. Over the last 5 years it fell 1.2% a year, and over the last 3 years it grew 10.8%.
Analysts expect Target's revenue to grow 2.8% a year until 2028. Over the last 5 years it grew 2.3% a year, and over the last 3 years it fell 1.3%.
Revenue
EPS
Does Target beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 19.6% off the result, either way, and their revenue estimate 1.9%, over the last 12 quarters.
- EPS beats
- 89 / 129
- Revenue beats
- 82 / 113
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +13.3%
- Since
- March 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q2 FY2027 | 19 Aug 2026 | 2.35 | 4.11 | +74.9% | 26.13B | 26.54B | +1.6% |
| Q1 FY2027 | 20 May 2026 | 1.47 | 1.71 | +16.3% | 24.66B | 25.44B | +3.2% |
| Q4 FY2026 | 3 Mar 2026 | 2.16 | 2.44 | +13.0% | 30.46B | 30.45B | -0.0% |
| Q3 FY2026 | 19 Nov 2025 | 1.71 | 1.78 | +4.1% | 25.32B | 25.27B | -0.2% |
| Q2 FY2026 | 20 Aug 2025 | 2.04 | 2.05 | +0.5% | 24.94B | 25.21B | +1.1% |
| Q1 FY2026 | 21 May 2025 | 1.56 | 1.30 | -16.7% | 24.14B | 23.85B | -1.2% |
| Q4 FY2025 | 4 Mar 2025 | 2.27 | 2.41 | +6.2% | 30.76B | 30.92B | +0.5% |
| Q3 FY2025 | 20 Nov 2024 | 2.30 | 1.85 | -19.6% | 25.87B | 25.67B | -0.8% |
| Q2 FY2025 | 21 Aug 2024 | 2.18 | 2.57 | +17.9% | 25.19B | 25.45B | +1.0% |
| Q1 FY2025 | 22 May 2024 | 2.06 | 2.03 | -1.5% | 24.51B | 24.53B | +0.1% |
| Q4 FY2024 | 5 Mar 2024 | 2.42 | 2.98 | +23.1% | 31.89B | 31.92B | +0.1% |
| Q3 FY2024 | 15 Nov 2023 | 1.48 | 2.10 | +41.9% | 29.18B | 25.40B | -12.9% |
Target stock price 2027–2031: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Target's earnings keep growing at the 11.8% a year analysts expect to FY2029, it would earn about 13.22 a share in FY2031. At the P/E it has traded at over the last five years (12.9 to 28.0) that is 170.85 to 370.00 a share, or 230.17 at its average P/E of 17.4. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2027 | 10.22 | 132.06 | 177.91 | 286.00 |
| FY2028 | 9.66 | 124.90 | 168.27 | 270.50 |
| FY2029 | 10.58 | 136.70 | 184.17 | 296.05 |
| FY2030 (extrapolated) | 11.82 | 152.83 | 205.89 | 330.97 |
| FY2031 (extrapolated) | 13.22 | 170.85 | 230.17 | 370.00 |
Each year's EPS is the analysts' consensus to FY2029; the years after grow 11.8% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (12.9, 17.4, 28.0).
Is Target stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Target's P/E of 16.5 is above the middle of its 5-year range (9.7 to 22.7, median 15.6). Analysts expect faster growth than in recent years, which can explain part of the high P/E. At its usual P/E (15.6 × EPS of 9.68), Target's fair value is 150.64; the price, 159.84, is 6.1% above it. Its forward P/E, on the consensus for FY2027, is 15.6.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (9.7 and 22.7). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 16.51
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 15.56
- Five-year P/E range
- 9.7 – 22.7
- Forward P/E (FY2027)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 15.64
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 1.40
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +4.4%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.850 | 71.4258Price 35.85193 | +99.2% | |
| 29.050 | 56.2634Price 29.0596 | +93.7% | |
| 241.000 | 464.49205Price 241.00627 | +92.7% | |
| 123.590 | 237.24178Price 123.59297 | +92.0% | |
| 161.400 | 305.52159Price 161.40396 | +89.3% | |
| 157.460 | 297.58169Price 157.46471 | +89.0% | |
| 217.560 | 405.38304Price 217.56507 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.